Nucleotide excision repair is a potential therapeutic target in multiple myeloma

Despite the development of novel drugs, alkylating agents remain an important component of therapy in multiple myeloma (MM). DNA repair processes contribute towards sensitivity to alkylating agents and therefore we here evaluate the role of nucleotide excision repair (NER), which is involved in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Szalat, R, Samur, M K, Fulciniti, M, Lopez, M, Nanjappa, P, Cleynen, A, Wen, K, Kumar, S, Perini, T, Calkins, A S, Reznichenko, E, Chauhan, D, Tai, Y-T, Shammas, M A, Anderson, K C, Fermand, J-P, Arnulf, B, Avet-Loiseau, H, Lazaro, J-B, Munshi, N C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720937/
https://www.ncbi.nlm.nih.gov/pubmed/28588253
http://dx.doi.org/10.1038/leu.2017.182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720937/
https://www.ncbi.nlm.nih.gov/pubmed/28588253
http://dx.doi.org/10.1038/leu.2017.182

Ejemplares similares